Monsanto Roundup Lawsuit

Tuesday, September 07, 2010

GlaxoSmithKline shares hit by call to withdraw Avandia

Image: bclba.co.nz


From UK market

Glaxo shares are biggest FTSE faller after MHRA medical experts say Avandia risks outweigh benefits

GlaxoSmithKline was the biggest faller in the FTSE 100 today after British medical experts demanded that Avandia, its controversial diabetes pill, be withdrawn from sale in the UK.

Glaxo closed down 19.5p at £12.49.


More HERE

Other Avandia related stories over the past 24 hours:

The Telegraph - GSK shares hit by diabetes drug warning

Pharmacy News - Avandia cover up denial

Irish Independent - 5,000 diabetes patients told to keep taking 'risky' drug

Economic Times - Glaxo's Avandia should be pulled from market: BMJ

Daily Mail - GSK vows to stick by controversial diabetes drug

GSK - GlaxoSmithKline Right of Reply Statement About Controversial BBC Programme, Panorama.

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment